Amazon cover image
Image from Amazon.com

Clinician's guide to antiepileptic drug use / Michael D. Privitera ... [and others].

Contributor(s): Material type: TextTextPublisher: Philadelphia, Pa. ; London : Lippincott Williams and Wilkins, 2006Description: viii, 167 pages : illustrations ; 21 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 078176064X (pbk.)
Subject(s): DDC classification:
  • 615.784 23 C.L.I.
Contents:
Carbamazepine -- Felbamate -- Gabapentin -- Lamotrigine -- Levetiracetam -- Oxcarbazepine -- Phenobarbital, primidone -- Phenytoin -- Pregabalin -- Tiagabine -- Topiramate -- Valproate acid -- Zonisamide.
Summary: Designed for quick point-of-care reference, this handbook offers evidence-based guidelines on use of antiepileptic drugs for seizures, psychiatric disorders, pain, and headache. Chapters cover all drugs, including the recently approved drug pregabalin. For each drug, the authors list FDA-approved indications and summarize the evidence for efficacy and tolerability from clinical trials for epileptic, psychiatric, pain, and headache indications. Also included are recommendations from professional societies such as the American Academy of Neurology, American Psychiatric Association, and Associat.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode Item holds
Books Books Media and mass communication Library X3 615.784 C.L.I. Available M0000382
Total holds: 0

Includes bibliographical references and index.

Carbamazepine -- Felbamate -- Gabapentin -- Lamotrigine -- Levetiracetam -- Oxcarbazepine -- Phenobarbital, primidone -- Phenytoin -- Pregabalin -- Tiagabine -- Topiramate -- Valproate acid -- Zonisamide.

Designed for quick point-of-care reference, this handbook offers evidence-based guidelines on use of antiepileptic drugs for seizures, psychiatric disorders, pain, and headache. Chapters cover all drugs, including the recently approved drug pregabalin. For each drug, the authors list FDA-approved indications and summarize the evidence for efficacy and tolerability from clinical trials for epileptic, psychiatric, pain, and headache indications. Also included are recommendations from professional societies such as the American Academy of Neurology, American Psychiatric Association, and Associat.

There are no comments on this title.

to post a comment.